Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Leishmania donovani proteasome is a multicatalytic proteinase complex essential for regulated protein degradation in the parasite. It plays a crucial role in cell cycle regulation, differentiation, signal transduction, immune response modulation, stress signaling, and apoptosis. Selective inhibitors targeting the chymotrypsin-like activity of the β5 subunit have been developed due to structural differences compared to the human proteasome, making it an attractive drug target for visceral leishmaniasis.
Inhibition of chymotrypsin-like activity (β5 subunit)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leishmania donovani Proteasome (Ld Proteasome).